Studies on the utility of simultaneous-multi-slice acquisition (SMS) dynamic susceptibility contrast-enhanced (DSC)MRI for the occulusive cerebrobascular disease

Studies on the utility of simultaneous-multi-slice acquisition (SMS) dynamic susceptibility contrast-enhanced (DSC)MRI for the occulusive cerebrobascular disease - Studies on the utility of simultaneous-multi-slice acquisition (SMS) dynamic susceptibility contrast-enhanced (DSC)MRI for the occulusive cerebrobascular disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000028938

Enrollment

Registered

2017-09-01

Start date

2017-09-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

occulusive cerebrobascular disease(moyamoya disease, ICA stenosis)

Interventions

administration of gadolimium contrast media

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult patients with occulusive cerebrobascular disease scheduled for perfusuion MRI examination.

Exclusion criteria

Exclusion criteria: Patietns with a contraindication for the administration of gadolinium contrast media. Patients determinded to be ineligible to principal investigator.

Design outcomes

Primary

Measure	Time frame
The perfusion measurements as well as the image quality of CBF, CBV, MTT, TTP, Tmax maps, created with temporal resolution of 0.5s (high temporal resoltuion), and conventional temporal resolution of 1.0, 1.5, and 2.0s (low temopral resolution).	—

Countries

Japan

Contacts

Public ContactTomohiro Takamura

Juntendo University School of Medicine Department of Radiology

t-takamura@juntendo.ac.jp03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026